JPRN-UMIN000011681
Completed
Phase 2
Phase II study of nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer - Phase II study of ABI + CBDCA + TRT for unresectable LA-NSCLC
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Gifu Municipal Hospital
- Enrollment
- 32
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Active double cancer. 2\)Active infections requiring systemic treatment. 3\)Serious complications(e.g. heart failure, renal failure, hepatic failure, haemorrhagic peptic ulcer, intestinal paralysis, intestinal obstruction or poorly controlled diabetes) 4\)Grade2 or higher peripheral neuropathy. 5\)Positive HBs antigen and/or HCV antibody. 6\)History of severe drug allergy. 7\)History of hypersensivity for albumin\-containing agents. 8\)Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers.Males that are currently attempting to produce a pregnancy. 9\)Judged ineligible by physicians for participation in the study from a safety viewpoint.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Phase II Study of Nab-paclitaxel and Carboplatin Plus Bevacizumab as First-Line Chemotherapy for Reccurent or stage IIIB and IV Nonsquamous Non-Small-Cell Lung Cancer (ALCT004)on-squamous non-small-cell lung cancerJPRN-UMIN000013310Kyorin University School of Medicine33
Recruiting
Phase 1
Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLCJPRN-UMIN000020359Gunma University50
Completed
Not Applicable
Phase II trial of nab-paclitaxel and carboplatin with concurrent radiotherapy for patients with locally advanced non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000019611Department of Radiation Oncology, Yamaguchi University Hospital37
Completed
Phase 2
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
Recruiting
Phase 1
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35